You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

marker tumor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study on AUNIP as a Novel Tumor Marker for Cervical Cancer

Not yet recruiting
  • Cervical Cancer
  • Detection of serum AUNIP expression
  • (no location specified)
Nov 6, 2023

1 asPotential Biomarker for Colorectal Cancer Diagnosis and

Not yet recruiting
  • Colorectal Cancer
  • Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
  • (no location specified)
Mar 20, 2023

Ovarian Cancer Trial in Boston (Zafirlukast)

Recruiting
  • Ovarian Cancer
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 11, 2022

Bladder Cancer Trial (urinary micro RNA detection)

Not yet recruiting
  • Bladder Cancer
  • urinary micro RNA detection
  • (no location specified)
Jan 15, 2023

Coplanar Template Assistance for Abdominal Tumor Puncture

Recruiting
  • Abdominal Tumor
    • Beijing, China
      Department of Radiation Oncology of Peking university third hosp
    Jul 18, 2022

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    Colon Cancer Trial in Atlanta (Chiropractic high velocity low amplitude adjustment, Light touch with low amplitude low-velocity

    Recruiting
    • Colon Cancer
    • Chiropractic high velocity low amplitude adjustment
    • Light touch with low amplitude low-velocity intervention to back
    • Atlanta, Georgia
      Dr. Sid E. Williams Center for Chiropractic Research
    Aug 3, 2022

    Breast Cancer Trial in Oslo (Docetaxel)

    Completed
    • Breast Cancer
    • Oslo, Norway
      RRHF
    Apr 21, 2022

    Melanoma Trial in Fairway (tvs-CTL Vaccine)

    Completed
    • Melanoma
    • tvs-CTL Vaccine
    • Fairway, Kansas
      KU Cancer Center
    Jan 20, 2022

    COGNITION: Genomics-Guided Precision Oncology in Early High-Risk

    Recruiting
    • Early-Stage Breast Cancer
    • Neoadjuvant Therapy
    • Genomic Profiling / Sequencing
    • Berlin, Germany
    • +4 more
    Jun 19, 2023

    CATCH: Implementation of Genomics-guided Precision Medicine in

    Recruiting
    • Metastatic Breast Cancer
    • Genomic Profiling / Sequencing
    • Berlin, Germany
    • +4 more
    Dec 7, 2022

    Circulating Tumour DNA asPrognostic and Predictive Marker in

    Recruiting
    • Colorectal Cancer
      • Oslo, Norway
      • +7 more
      Apr 13, 2022

      Response to Antineoplastic Treatment of Metastatic Cancer

      Recruiting
      • Metastatic Cancer
      • blood sample collection
      • Linz, Upper Austria, Austria
        Ordensklinikum Linz
      Mar 9, 2021

      Treatment Efficacy in Patients With Ovarian Cancer

      Not yet recruiting
      • High-grade Serous Ovarian Cancer
      • Circulating Tumor DNA
        • (no location specified)
        Aug 25, 2021

        NSCLC Trial in Changsha (Sintilimab Combined With Docetaxel)

        Completed
        • Non-small Cell Lung Cancer
        • Sintilimab Combined With Docetaxel
        • Changsha, Hunan, China
          Hunan Provincal Tumor Hospital
        Mar 1, 2022

        Cancer, Brain Tumors Trial in Salt Lake City (FLT-PET Imaging)

        Completed
        Has Results
        • Cancer
        • Brain Tumors
        • FLT-PET Imaging
        • Salt Lake City, Utah
          Huntsman Cancer Institute
        Sep 20, 2021

        Insertion for Real-time Stereotactic-guided Radiotherapy in Lung

        Recruiting
        • Lung Cancer
        • +2 more
        • Endovascular fiducial marker insertion
        • Bronchoscopic fiducial marker insertion
        • Lausanne, VD, Switzerland
          Centre Hospitalier Universitaire vaudois - Department of Radiolo
        Jan 8, 2021

        Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation Trial in United States (drug, diagnostic test, other)

        Recruiting
        • Pancreas Cancer
        • +4 more
        • New Haven, Connecticut
        • +7 more
        Dec 12, 2022

        The Immunoscore as a Prognostic Marker for a Colorectal Cancer

        Active, not recruiting
        • Colorectal Cancer
        • Surgical Resection of the Colorectal Tumor
          • Besançon, France
          • +5 more
          Oct 11, 2021

          Pancreatic Cancer Trial (Microsieve device, Cell surface marker-based platform)

          Not yet recruiting
          • Pancreatic Cancer
          • Microsieve device
          • Cell surface marker-based platform
          • (no location specified)
          Nov 19, 2020

          Colorectal Cancer, Peritoneal Metastases Trial in Guangzhou (ctDNA monitoring, Imageology)

          Recruiting
          • Colorectal Cancer
          • Peritoneal Metastases
          • ctDNA monitoring
          • Imageology
          • Guangzhou, Guangdong, China
            Sixth Affiliated Hospital, Sun Yat-sen University
          Feb 9, 2021

          Glioblastoma, Molecular Disease Trial in Amiens (Correlation between molecular anomalies of the primary tumor and circulating

          Terminated
          • Glioblastoma
          • Molecular Disease
          • Correlation between molecular anomalies of the primary tumor and circulating tumor DNA
          • Amiens, Picardie, France
            CHU Amiens Picardie
          Jul 13, 2020

          Prostate Cancer Trial in Philadelphia (Obtaining biospecimen)

          Completed
          • Prostate Cancer
          • Obtaining biospecimen
          • Philadelphia, Pennsylvania
            Abramson Cancer Center of the University of Pennsylvania
          Jul 20, 2020

          ALDH1A1 Expression in Invasive Mammary Carcinoma

          Enrolling by invitation
          • Breast Cancer
            • Sohag, Egypt
              Faculty of Medicine
            Nov 12, 2023

            Germ Cell Tumor Trial in Bratislava (Paclitaxel, Ifosfamide, Cisplatin)

            Completed
            • Germ Cell Tumor
            • Bratislava, Slovakia
              National Cancer Institute
            Aug 5, 2020